Alejandro Zapata
Psychiatry · Sterling Heights, MINPI 1467461855
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 374 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,648 and has fallen 57.7% since, to $1,121 in 2023. Among psychiatry clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 374 payments — averaging $23.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Alkermes, Inc.$1K
- AbbVie$905
- Johnson & Johnson$877
- Sunovion Pharmaceuticals Inc.$873
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$768
- plus $3K from 18 others
What the payments were for
- Food & beverage$8,81999%
- Education$601%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 47 | $1,467 |
| Alkermes, Inc. | 42 | $1,359 |
| AbbVie(2 entities) | 57 | $905 |
| Johnson & Johnson | 52 | $877 |
| Sunovion Pharmaceuticals Inc. | 53 | $873 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $768 |
| Neurocrine Biosciences, Inc. | 12 | $581 |
| Lundbeck LLC | 33 | $523 |
| Validus Pharmaceuticals LLC | 9 | $245 |
| Avanir Pharmaceuticals, Inc. | 8 | $245 |
| Ironshore Pharmaceuticals Inc. | 6 | $232 |
| Vanda Pharmaceuticals Inc. | 8 | $163 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $161 |
| Teva Pharmaceuticals USA, Inc. | 6 | $116 |
| Axsome Therapeutics, Inc. | 1 | $71 |
| Corium, LLC | 3 | $59 |
| Shire North American Group Inc | 4 | $54 |
| Supernus Pharmaceuticals, Inc. | 3 | $44 |
| Bausch Health US, LLC | 2 | $39 |
| Indivior Inc. | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Adlon Therapeutics L.p. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Tris Pharma Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,451
- ARISTADA$1,000
- REXULTI$585
- CAPLYTA$456
- VRAYLAR$363
- INGREZZA$353
- ARISTADA INITIO$250
- NUEDEXTA$129
- JORNAY PM$121
- INVEGA SUSTENNA$121
- Equetro$118
- ABILIFY MAINTENA$108
How this compares
$8,879 in reported general payments places this provider in the 90th percentile of 1,166 psychiatry providers in Michigan.
Other psychiatry in Sterling Heights
- Robert BurnsteinSterling Heights$18K
- Edgard PedrazaSterling Heights$16K
- Robert PiccininiSterling Heights$12K
- Nina AndersonSterling Heights$12K
- Andreas SidiropoulasDetroit$2.8M
- Welton WashingtonYpsilanti$1.4M
- Joel YoungRochester Hills$1.1M
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
- Robert LagrouClarkston$267K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.